% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I4210151718&about=side-effects
% 10 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{teng2022-35696185,
  author  = {Teng, E. and Manser, P. T. and Pickthorn, K. and Brunstein, F. and Blendstrup, M. and Sanabria Bohorquez, S. and Wildsmith, K. R. and Toth, B. and others},
  title   = {{Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2022.1375},
  pmid    = {35696185},
  url     = {https://doi.org/10.1001/jamaneurol.2022.1375}
}

@article{dubois2012-22915447,
  author  = {Dubois, B. and Tolosa, E. and Katzenschlager, R. and Emre, M. and Lees, A. J. and Schumann, G. and Pourcher, E. and Gray, J. and others},
  title   = {{Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study}},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  year    = {2012},
  doi     = {10.1002/mds.25098},
  pmid    = {22915447},
  url     = {https://doi.org/10.1002/mds.25098}
}

@article{kishnani2009-19606472,
  author  = {Kishnani, P. S. and Sommer, B. R. and Handen, B. L. and Seltzer, B. and Capone, G. T. and Spiridigliozzi, G. A. and Heller, J. H. and Richardson, S. and others},
  title   = {{The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome}},
  journal = {American journal of medical genetics. Part A},
  year    = {2009},
  doi     = {10.1002/ajmg.a.32953},
  pmid    = {19606472},
  url     = {https://doi.org/10.1002/ajmg.a.32953}
}

@article{tariot2001-11843990,
  author  = {Tariot, P. N. and Cummings, J. L. and Katz, I. R. and Mintzer, J. and Perdomo, C. A. and Schwam, E. M. and Whalen, E.},
  title   = {{A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2001},
  doi     = {10.1111/j.1532-5415.2001.49266.x},
  pmid    = {11843990},
  url     = {https://doi.org/10.1111/j.1532-5415.2001.49266.x}
}

@article{rogers2000-10793322,
  author  = {Rogers, S. L. and Doody, R. S. and Pratt, R. D. and Ieni, JR.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {2000},
  doi     = {10.1016/s0924-977x(00)00067-5},
  pmid    = {10793322},
  url     = {https://doi.org/10.1016/s0924-977x(00)00067-5}
}

@article{rogers1998-9452942,
  author  = {Rogers, S. L. and Friedhoff, L. T.},
  title   = {{Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study}},
  journal = {European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology},
  year    = {1998},
  doi     = {10.1016/s0924-977x(97)00079-5},
  pmid    = {9452942},
  url     = {https://doi.org/10.1016/s0924-977x(97)00079-5}
}

@article{vandyck2025-41355080,
  author  = {van Dyck, C. H. and Sperling, R. and Johnson, K. and Dhadda, S. and Kanekiyo, M. and Li, D. and Gee, M. and Hersch, S. and Irizarry, M. and Kramer, L.},
  title   = {{Long-term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the Clarity AD open-label extension study}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70905},
  pmid    = {41355080},
  url     = {https://doi.org/10.1002/alz.70905}
}

@article{chen2025-40189473,
  author  = {Chen, Christopher and Katayama, Sadao and Lee, Jae Hong and Lee, Jun-Young and Nakagawa, Masaki and Torii, Kentaro and Ogawa, Tomoo and Dash, Amitabh and others},
  title   = {{Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer s Disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100160},
  pmid    = {40189473},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100160}
}

@article{hampel2023-37280110,
  author  = {Hampel, H. and Elhage, A. and Cho, M. and Apostolova, L. G. and Nicoll, J. A. R. and Atri, A.},
  title   = {{Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad188},
  pmid    = {37280110},
  url     = {https://doi.org/10.1093/brain/awad188}
}

@article{zhou2025-41447712,
  author  = {Zhou, Jin and Andreozzi, Erica M. and Llibre‐Guerra, Jorge J. and Clifford, David B. and Li, David and Wang, Guoqiao and Schneider, Lon S. S. and McDade, Eric and others},
  title   = {{Safety of Lecanemab After 6‐Month Treatment in the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105304},
  pmid    = {41447712},
  url     = {https://doi.org/10.1002/alz70859_105304}
}